hf 2022: ccm therapy in patients with hfpef | dr cecilia linde
Published 2 years ago • 640 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
7:14
hf 2022: rebalance-hf: catheter-based ablation of the gsn in pts with hfpef | dr marat fudim
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
4:43
hf 2022: helios-a: phase 3 study of vutrisiran in patients with hattr amyloidosis | dr garcia-pavia
-
4:06
hf 2022: 2022 heart failure highlights with dr mikhail kosiborod
-
5:44
cardiac resynchronisation therapy (or crt) video interview with cecilia linde
-
2:41
hf 2022: heart failure highlights with prof giuseppe rosano
-
2:55
an overview of ccm therapy for medical professionals (english w ce mark indications)
-
7:42
hfsa 2022: prove-hf: effect of sacubitril/valsartan in hfref pts with mr | dr james l januzzi
-
2:41
an overview of ccm therapy for medical professionals
-
4:07
hf 2022: heart failure highlights of 2022 with prof john cleland
-
1:04:03
hfpef series treatments
-
9:04
accel: cecilia linde, md
-
13:22
usc discussion 2022: vulnerable plaque in patients with acs
-
5:21
linc 2022: patient selection in nivl and preventing migration in venous stenting with dr kush desai
-
5:34
hrs 22: results from the multicenter us cardioneural ablation registry | dr roderick tung
-
4:15
ccm therapy - the mechanism of action explained
-
53:45
is hfpef a reversible cardiomyopathy? evolving concepts
-
14:15
radcliffe & cardionerds @aha22: the respect epa trial